Free Access
Review
Issue
J Extra Corpor Technol
Volume 46, Number 3, September 2014
Page(s) 197 - 211
DOI https://doi.org/10.1051/ject/201446197
Published online 15 September 2014
  1. Prondzinsky R, Knupfer A, Loppnow H, et al. Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;129:760–766. [CrossRef] [Google Scholar]
  2. Bittar N, Koke JR, Berkoff HA, Kahn DR. Histochemical and structural changes in human myocardial cells after cardiopulmonary bypass. Circulation. 1975;52Suppl:I16–I25. [CrossRef] [PubMed] [Google Scholar]
  3. Freeman R, Gould FK. Rises in antibody to enteric gram negative bacilli after open heart surgery: A possible mechanism for postoperative pyrexia. Thorax. 1985;40:538–541. [CrossRef] [PubMed] [Google Scholar]
  4. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497–503. [CrossRef] [PubMed] [Google Scholar]
  5. Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant? Thromb Haemost. 1993;70:259–262. [CrossRef] [PubMed] [Google Scholar]
  6. Kang HM, Kalnoski MH, Frederick M, Chandler WL. The kinetics of plasmin inhibition by aprotinin in vivo. Thromb Res. 2005;115:327–340. [CrossRef] [Google Scholar]
  7. Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg. 1993;106:1–9. [CrossRef] [Google Scholar]
  8. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits. Br J Anaesth. 1995;75:724–733. [CrossRef] [Google Scholar]
  9. Christen S, Finckh B, Lykkesfeldt J, et al. Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation. Free Radic Biol Med. 2005;38:1323–1332. [CrossRef] [Google Scholar]
  10. Philippidis P, Mason JC, Evans BJ, et al. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res. 2004;94:119–126. [CrossRef] [PubMed] [Google Scholar]
  11. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 1995;110:1658–6162. [CrossRef] [Google Scholar]
  12. Ferraris VA, Ferraris SP, Singh A, et al. The platelet thrombin receptor and postoperative bleeding. Ann Thorac Surg. 1998;65:352–358. [CrossRef] [Google Scholar]
  13. Edmunds LHJr. Blood-surface interactions during cardiopulmonary bypass. J Card Surg. 1993;8:404–410. [CrossRef] [PubMed] [Google Scholar]
  14. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552–559. [CrossRef] [Google Scholar]
  15. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg. 2001;71:745–754. [CrossRef] [Google Scholar]
  16. Boyle EMJr, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response. Ann Thorac Surg. 1997;63:277–284. [CrossRef] [Google Scholar]
  17. Landis RC, Brown JR, Murkin JM, Likosky DS, Baker RA. An evidence based review of pharmaceutical interventions to limit the systemic inflammatory response in coronary surgery. Heart Surg Forum. 2008;11:E307. [Google Scholar]
  18. Landis RC. 20 years on: Is it time to redefine the systemic inflammatory response to cardiothoracic surgery? J Extra Corpor Technol. (in press). [Google Scholar]
  19. Clive Landis R, Murkin JM, Stump DA, et al. Consensus statement: Minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum. 2010;13:E116–E123. [Google Scholar]
  20. Gibbons RJ, Smith S, Antman E. American College of Cardiology/American Heart Association clinical practice guidelines: Part I: Where do they come from? Circulation. 2003;107:2979–2986. [CrossRef] [PubMed] [Google Scholar]
  21. Dieleman JM. van Paassen J, van Dijk D, et al. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev. 2011;5:CD005566. [Google Scholar]
  22. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352–360. [CrossRef] [Google Scholar]
  23. McNeely TB, Griffith MJ. The anticoagulant mechanism of action of heparin in contact-activated plasma: Inhibition of factor X activation. Blood. 1985;65:1226–1231. [CrossRef] [PubMed] [Google Scholar]
  24. Harpel PC, Cooper NR. Studies on human plasma C1 inactivator–enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin. J Clin Invest. 1975;55:593–604. [CrossRef] [PubMed] [Google Scholar]
  25. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524–526. [CrossRef] [PubMed] [Google Scholar]
  26. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88:4651–4655. [CrossRef] [PubMed] [Google Scholar]
  27. Glusa E, Markwardt F, Sturzebecher J. Effects of sodium nitroprusside and other pentacyanonitrosyl complexes on platelet aggregation. Haemostasis. 1974;3:249–256. [PubMed] [Google Scholar]
  28. Landis RC, de Silva RJ. The systemic inflammatory response to cardiopulmonary bypass. In: Mackay JH, Arrowsmith JE, eds. Core Topics in Cardiac Anaesthesia. 2nd ed. Cambridge, UK: Cambridge University Press; 2012. [Google Scholar]
  29. Miller BE, Levy JH. The inflammatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:355–366. [CrossRef] [Google Scholar]
  30. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283–290. [CrossRef] [Google Scholar]
  31. Zhu X, Ji B, Wang G, Liu J, Long C. The effects of zero-balance ultrafiltration on postoperative recovery after cardiopulmonary bypass: A meta-analysis of randomized controlled trials. Perfusion. 2012;27:386–392. [CrossRef] [PubMed] [Google Scholar]
  32. Warren O, Wallace S, Massey R, et al. Does systemic leukocyte filtration affect perioperative hemorrhage in cardiac surgery? A systematic review and meta-analysis. ASAIO J. 2007;53:514–521. [CrossRef] [PubMed] [Google Scholar]
  33. Ranucci M, Balduini A, Ditta A, Boncilli A, Brozzi S. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg. 2009;87:1311–1319. [CrossRef] [Google Scholar]
  34. Anastasiadis K, Antonitsis P, Haidich AB, Argiriadou H, Deliopoulos A, Papakonstantinou C. Use of minimal extracorporeal circulation improves outcome after heart surgery; a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2013;164:158–169. [CrossRef] [Google Scholar]
  35. Dieleman JM, Nierich AP, Rosseel PM, et al. Intraoperative high-dose dexamethasone for cardiac surgery: A randomized controlled trial. JAMA. 2012;308:1761–1767. [CrossRef] [PubMed] [Google Scholar]
  36. Moller CH, Penninga L, Wetterslev J, Steinbruchel DA, Gluud C. Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease. Cochrane Database Syst Rev. 2012;3:CD007224. [Google Scholar]
  37. Rimpilainen R, Hautala N, Koskenkari JK, et al. Minimized cardiopulmonary bypass reduces retinal microembolization: A randomized clinical study using fluorescein angiography. Ann Thorac Surg. 2011;91:16–22. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.